Page last updated: 2024-08-20

dydrogesterone and Osteoporosis, Postmenopausal

dydrogesterone has been researched along with Osteoporosis, Postmenopausal in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	8 (50.00)	18.2507
2000's	5 (31.25)	29.6817
2010's	3 (18.75)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deng, Y; Ma, X; Sun, A; Wang, YF; Xue, W; Zhu, SY	1
Deng, Y; Gao, L; Ma, X; Sun, A; Wang, Y; Xin, H; Xue, W; Zhu, S; Zuo, H	1
Panay, N; Pexman-Fieth, C; Stevenson, JC	1
Benussi, C; Bevilacqua, G; Cappagli, B; Ciaponi, M; Gambacciani, M; Genazzani, AR; Monteleone, P	1
Barnett, AH; Kumar, S; Palin, SL; Sturdee, DW	1
Benraad, TJ; Rolland, R; Swinkels, LM; van der Mooren, MJ; van Hoof, HJ	1
Blum, M; Friedman, J; Kaplan, B; Kitai, E; Neri, A; Pardo, Y	1
Bertinetti, G; Dell'Elce, C; Delzanno, G; Gaudiano, L; Paoletti, R; Ventrella, CA	1
Chappard, C; De Vernejoul, MC; Dougados, M; Kolta, S; Morieux, C; Roux, C	1
Dain, MP; MacCarthy, K; Studd, JW; Zamblera, D	1
Birkhaeuser, MH; Casez, JP; Haenggi, W; Jaeger, P; Lippuner, K	1
Balfour, JA; Foster, RH	1
Chambers, TJ; Chow, J; Fox, S; Patel, S; Pazianas, M; Tobias, J	1
Lazebniuk, LB; Melchenko, SB	1
Lees, B; Stevenson, JC; Teter, P	1
Lees, B; Stevenson, JC	1

Reviews

2 review(s) available for dydrogesterone and Osteoporosis, Postmenopausal

Article	Year
Oral estradiol and dydrogesterone combination therapy in postmenopausal women: review of efficacy and safety. Maturitas, 2013, Volume: 76, Issue:1 Topics: Blood Glucose; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipid Metabolism; Menopause; Osteoporosis, Postmenopausal; Progestins	2013
Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women. Drugs & aging, 1997, Volume: 11, Issue:4 Topics: Aged; Bone Density; Climacteric; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause	1997

Trials

11 trial(s) available for dydrogesterone and Osteoporosis, Postmenopausal

Article	Year
Bone protection for early menopausal women in China: standard or half-dose estrogen with progestin? A one-year prospective randomized trail. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2019, Volume: 35, Issue:2 Topics: Alanine Transaminase; Alkaline Phosphatase; Bone Density; Calcium; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estrogens; Estrogens, Conjugated (USP); Female; Femur Neck; Fractures, Bone; Humans; Lumbar Vertebrae; Middle Aged; Organ Size; Osteoporosis, Postmenopausal; Phosphorus; Progestins	2019
Effect of Menopausal Hormone Therapy on Bone Mineral Density in Chinese Women: A 2-Year, Prospective, Open-Label, Randomized-Controlled Trial. Medical science monitor : international medical journal of experimental and clinical research, 2019, Jan-28, Volume: 25 Topics: Aged; Aged, 80 and over; Asian People; Bone Density; China; Dydrogesterone; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Progesterone; Prospective Studies	2019
Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy. Maturitas, 2003, Jul-25, Volume: 45, Issue:3 Topics: Drug Therapy, Combination; Dydrogesterone; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Femur; Humans; Megestrol; Middle Aged; Osteoporosis, Postmenopausal; Progesterone Congeners; Prospective Studies	2003
Hormone replacement therapy increases serum 1,25-dihydroxyvitamin D: A 2-year prospective study. Calcified tissue international, 1994, Volume: 55, Issue:6 Topics: Administration, Oral; Bone Resorption; Calcitriol; Cholecalciferol; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Humans; Longitudinal Studies; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Radioligand Assay	1994
Low dose estrogen replacement therapy in early postmenopausal women effect on urinary magnesium and calcium: creatinine ratios. Clinical and experimental obstetrics & gynecology, 1994, Volume: 21, Issue:3 Topics: Administration, Cutaneous; Calcium; Creatinine; Dydrogesterone; Estrogen Replacement Therapy; Estrogens; Exercise; Female; Humans; Magnesium; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause	1994
[Dihydrogesterone vs. medroxyprogesterone acetate in association with transdermal estradiol in postmenopausal substitution treatment]. Minerva ginecologica, 1994, Volume: 46, Issue:4 Topics: Administration, Cutaneous; Bone Density; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal	1994
Efficacy and safety of Menorest (50 mikrog/day) compared to Premarin 0.625 mg in the treatment of menopausal symptoms and the prevention of bone loss, in menopausal women. A single-center, comparative, randomized, double-blind, double-dummy study. Scandinavian journal of rheumatology. Supplement, 1996, Volume: 103 Topics: Bone Density; Double-Blind Method; Dydrogesterone; Estradiol; Estrogens, Conjugated (USP); Female; Flushing; Humans; Menopause; Osteoporosis, Postmenopausal; Pilot Projects	1996
Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1997, Volume: 12, Issue:5 Topics: Absorptiometry, Photon; Administration, Cutaneous; Administration, Oral; Anabolic Agents; Bone Density; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Patient Compliance; Progesterone Congeners; Retrospective Studies	1997
Early effects of hormone replacement therapy on bone. Bone, 1999, Volume: 24, Issue:3 Topics: Absorptiometry, Photon; Amino Acids; Biomarkers; Bone Density; Bone Development; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Femur Neck; Follicle Stimulating Hormone; Humans; Ilium; Lumbar Vertebrae; Luteinizing Hormone; Middle Aged; Osteoporosis, Postmenopausal; Tetracycline	1999
17beta-estradiol (1 mg/day) continuously combined with dydrogesterone (5, 10 or 20 mg/day) increases bone mineral density in postmenopausal women. Maturitas, 2001, Apr-20, Volume: 38, Issue:2 Topics: Administration, Oral; Aged; Bone Density; Double-Blind Method; Dydrogesterone; Estradiol; Female; Hormone Replacement Therapy; Humans; London; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies	2001
The prevention of osteoporosis using sequential low-dose hormone replacement therapy with estradiol-17 beta and dydrogesterone. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2001, Volume: 12, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aging; Bone Density; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Prospective Studies; Time Factors	2001

Other Studies

3 other study(ies) available for dydrogesterone and Osteoporosis, Postmenopausal

Article	Year
A burning mouth associated with the use of hormone replacement therapy. The journal of the British Menopause Society, 2005, Volume: 11, Issue:1 Topics: Burning Mouth Syndrome; Diabetes Mellitus, Type 2; Diagnosis, Differential; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal	2005
Bone effects of dydrogesterone in ovariectomized rats: a biologic, histomorphometric, and densitometric study. Bone, 1996, Volume: 19, Issue:5 Topics: Analysis of Variance; Animals; Bone Density; Cell Count; Disease Models, Animal; Dydrogesterone; Estradiol; Female; Femur; Humans; Osteoclasts; Osteoporosis, Postmenopausal; Ovariectomy; Progesterone Congeners; Rats; Rats, Sprague-Dawley; Tibia	1996
[Clinical features of cardiovascular diseases in females with postmenopausal osteoporosis. Femostone treatment in late menopause]. Klinicheskaia meditsina, 2000, Volume: 78, Issue:7 Topics: Cardiovascular Diseases; Drug Combinations; Dydrogesterone; Estradiol; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Risk Factors	2000